a public good project by the
Synthesis
Company
of California

© 2026

Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil | doi.page

0 citations0 references

Google Scholar doi.org

Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil

European Journal of Cancer·2004·Vol. 40(7), pp. 939–950

Citations Over TimeTop 1% of 2004 papers

André B. P. Kuilenburg

Related Papers

→ DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report(2019)85 cited
5-Fluorouracil Chemotherapy for Dihydropyrimidine Dehydrogenase-deficient Patients: Potential of the Dose-escalation Method.(2015)
→ Increased dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil and leucovorin(2006)24 cited
[New recommendation on pharmacogenetic screening prior to 5-fluorouracil based cancer treatment - Swedish experience indicates less adverse effects and healthcare cost savings].(2021)
→ Study on Expression of 5-Fluorouracil-Related Enzymes, Thymidylate Synthase, and Dihydropyrimidine Dehydrogenase in Head and Neck Squamous Cell Carcinoma(2005)